Mesa Laboratories, Inc. MLAB
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.67M | 4.80M | 6.71M | 3.73M | -1.57M |
| Total Depreciation and Amortization | 22.67M | 22.96M | 23.27M | 25.02M | 24.80M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.95M | 22.03M | 17.84M | 12.01M | 17.83M |
| Change in Net Operating Assets | 1.27M | 5.89M | -4.99M | 771.00K | -150.00K |
| Cash from Operations | 51.55M | 55.67M | 42.83M | 41.53M | 40.91M |
| Capital Expenditure | -2.10M | -2.80M | -3.25M | -3.59M | -3.67M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -250.00K | -250.00K |
| Cash from Investing | -2.10M | -2.80M | -3.25M | -3.84M | -3.92M |
| Total Debt Issued | 10.00M | 107.00M | 107.50M | 107.50M | 107.50M |
| Total Debt Repaid | -53.44M | -145.47M | -134.25M | -137.50M | -138.25M |
| Issuance of Common Stock | 958.00K | 1.06M | 1.06M | 3.71M | 3.71M |
| Repurchase of Common Stock | -2.02M | -2.02M | -2.12M | -1.95M | -1.95M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.55M | -3.53M | -3.52M | -3.51M | -3.49M |
| Other Financing Activities | -309.00K | -966.00K | -10.52M | -10.54M | -10.30M |
| Cash from Financing | -48.36M | -43.93M | -41.85M | -42.29M | -42.79M |
| Foreign Exchange rate Adjustments | 793.00K | 467.00K | 1.88M | 2.61M | 1.89M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.89M | 9.42M | -393.00K | -1.98M | -3.92M |